SCHEMBL16811799

SCHEMBL16811799

Cc1ccc(-c2cc(C(=O)NC3CCN(Cc4ccc(N5CCC(C)CC5)nc4)CC3)ccc2F)cn1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 1/20 0.59
▸ MCHR1 Q99705 3/20 0.47
▸ SSTR5 P35346 4/20 0.46
▸ HPGDS O60760 4/20 0.45
▸ CCR3 P51677 3/20 0.45
▸ DRD4 P21917 2/20 0.44
▸ RET P07949 1/20 0.44
▸ NPC1 O15118 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CHRM1 P11229 1/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18286503 0.94 SMO (0.57) SMOMCHR1SSTR5HPGDSCCR3
SCHEMBL16811796 0.93 SMO (0.62) SMOMCHR1CCR3DRD4RET
SCHEMBL16811786 0.92 SMO (0.60) SMOSSTR5HPGDSDRD4NPC1
SCHEMBL16811830 0.91 SMO (0.73) SMOMCHR1SSTR5HPGDSDRD4
SCHEMBL16811808 0.91 SMO (0.61) SMOMCHR1SSTR5HPGDSCCR3
SCHEMBL16811783 0.91 SMO (0.59) SMOMCHR1SSTR5HPGDSDRD4
SCHEMBL16811791 0.90 SMO (0.54) SMOMCHR1SSTR5HPGDSCCR3
SCHEMBL16812720 0.89 SMO (0.52) SMOMCHR1SSTR5HPGDSCCR3
SCHEMBL16812010 0.88 SMO (0.79) SMOMCHR1SSTR5CCR3DRD4
SCHEMBL18286585 0.88 SMO (0.52) SMOMCHR1SSTR5HPGDSCCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 SMO 1/4885MCHR1 3063/4885SSTR5 1894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback